GWM
RTO icon

Geneos Wealth Management’s Rentokil RTO Stock Holding History

Geneos Wealth Management’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Sell
8,496
-640
-7% -$20.2K 0.01% 867
2025
Q4 		$269K Buy
9,136
+8,656
+1,803% +$240K 0.01% 830
2025
Q3 		$12.1K Sell
480
-126
-21% -$3.07K ﹤0.01% 1897
2025
Q2 		$14.5K Sell
606
-1,231
-67% -$28.5K ﹤0.01% 2169
2025
Q1 		$42.1K Buy
1,837
+1,143
+165% +$27.6K ﹤0.01% 2007
2024
Q4 		$17.6K Buy
+694
New +$17.6K ﹤0.01% 1791

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
SL
Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return

Geneos Wealth Management's RTO Position: Q1 2026 in Review

Geneos Wealth Management reduced its Rentokil (RTO) stake by 7% in Q1 2026, selling an estimated $20.2K and leaving 8,496 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #867.

Geneos Wealth Management first reported a position in RTO in Q4 2024 and has held it in 6 quarters since. The position peaked at $269K in Q4 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Geneos Wealth Management held 8,496 shares of Rentokil worth $267K as of Q1 2026.
  • Geneos Wealth Management sold 640 Rentokil shares in Q1 2026, an estimated $20.2K.
  • Rentokil made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #867 holding.
  • Geneos Wealth Management first reported a position in Rentokil in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's Rentokil position peaked at $269K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.